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Abstract
The Nationwide Inpatient Sample aggregated data from approximately 20% of US hospital 
admissions from 1993 to 2011. Prior literature found that pneumonia admissions decreased 
following the introduction of the pneumococcal vaccine in 2000.1 The International Classification 
of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), codes provide information 
regarding pneumonia pathogens, but no studies, to our knowledge, have used these codes to 
analyze longitudinal trends in the pathogens documented during hospitalizations for pneumonia.
METHODS
We selected patients 18 years or older admitted for pneumonia based on a principal 
diagnosis of pneumonia (ICD-9-CM codes 480.0–480.3, 480.8, 480.9, 481, 482.0–482.9, 
483.0–483.8, 485, 486, and 487). Consistent with recent literature,2 we also selected 
hospitalizations with pneumonia as a secondary diagnosis if the principal diagnosis was 
sepsis (ICD-9-CM codes 038.8, 038.9, 785.52, 995.91, and 995.92) or respiratory failure 
(ICD-9-CM codes 518.81, 518.82, 518.84, and 799.1). For each pathogen, we used a linear 
regression model with year of hospitalization as the explanatory variable and the percentage 
Copyright ©2015 American Medical Association
Corresponding Author: Sean B. Smith, MD, Department of Pulmonary and Critical Care Medicine, Northwestern University, 675 N St 
Clair St, Ste 18-250, Chicago, IL 60611 (sean@northwestern.edu). 
Conflict of Interest Disclosures: None reported.
Previous Presentation: A preliminary version of this work was presented as a poster at the American Thoracic Society International 
Conference; May 19, 2013; Philadelphia, Pennsylvania.
Author Contributions: Dr Smith had full access to all the data in the study and takes responsibility for the integrity of the data and 
the accuracy of the data analysis.
Study concept and design: Smith, Weiss, Waterer, Wunderink.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Smith, Ruhnke, Waterer, Wunderink.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Smith, Ruhnke.
Administrative, technical, or material support: Wunderink.
Study supervision: Ruhnke, Weiss, Waterer, Wunderink.
HHS Public Access
Author manuscript
JAMA Intern Med. Author manuscript; available in PMC 2015 February 16.
Published in final edited form as:
JAMA Intern Med. 2014 November ; 174(11): 1837–1839. doi:10.1001/jamainternmed.2014.4344.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
of cases coded with that pathogen as the dependent variable. We obtained annual population 
estimates from the US Census Bureau.3
RESULTS
From January 1, 1993, to December 31, 2011, hospitalizations for pneumonia increased 
from 910 676 to 1 378 551 (350.4 to 442.4 per 100 000 US population; P < .001) (Table and 
Figure). The proportion of admissions with no reported pathogen increased from 65.9% to 
83.9% (P < .001). Admissions with the nonpneumonia principal diagnoses were more likely 
to have pathogens documented (odds ratio, 1.28; 95% CI, 1.25–1.30; P < .001). From 1993 
to 2011, there were declines in the coding of streptococcal species (from 7.1% to 2.3%; P < .
001), Pseudomonas (from 3.9% to 2.3%; P < .001), and Haemophilus influenzae (from 3.6% 
to 0.4%; P < .001); however, the coding of Staphylococcus aureus increased (from 3.6% to 
3.9%; P = .004).
Streptococcal species, especially Streptococcus pneumoniae, were the most frequently coded 
pathogens in 1993. There were decreases in the documentation of streptococcal species, 
Haemophilus influenzae, and Pseudomonas, whereas documentation of Staphylococcus 
aureus increased modestly.
Unadjusted inpatient mortality did not change significantly (from 8.7% to 7.8%; P = .40). 
Cases coded with S aureus had the highest mortality (12.0%).
DISCUSSION
To our knowledge, this is the first analysis of trends in the microbiologic pathogens in 
patients hospitalized for pneumonia based on nationally representative data spanning nearly 
2 decades.
Streptococcus pneumoniae has been reported to be the most common cause of community-
acquired pneumonia.4 Declines in cases of adult pneumonia due to S pneumoniae may be 
related to more frequent and effective vaccination as well as to herd immunity from 
increased pediatric vaccination after 2000.1 In addition to prevention, vaccination reduces 
the risk of invasive pneumococcal disease and bacteremia. We hypothesize that this reduced 
risk may have resulted in less-frequent coding because more thorough diagnostic evaluations 
accompany a higher severity of disease.5 We observed a reduction in Streptococcus, despite 
the addition of urine antigen testing.6 Furthermore, quality improvement initiatives to reduce 
the time from presentation to antibiotic administration may also have reduced the yield of 
traditional culture-based diagnostics. We cannot know with certainty how the contributions 
of vaccination and changes in diagnostic tests affected the trends that we describe. However, 
we believe that our findings suggest important changes in pneumonia pathogens.
Streptococcuspneumoniae was the most frequent pathogen in 1993 and S aureus was the 
most frequent in 2011, most of which was methicillin-resistant S aureus (MRSA). Because 
we included hospitalizations with certain alternative principal diagnoses, it is likely that our 
case definition included some patients with health care–associated pneumonia, which may 
have increased our identification of MRSA. Despite the trends observed, the low incidence 
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of S aureus (<4%) suggests that MRSA coverage is not routinely indicated for patients with 
community-acquired pneumonia.7
We have described changes in pneumonia pathogens from hospital admissions during 2 
decades. We believe that these changes should be considered for public health monitoring 
and care for pneumonia, which is the leading cause of infectious death in the United States.
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Figure. 
Documentation of Specific Bacterial Pathogens for Pneumonia From 1993 to 2011 
Streptococcal species, especially Streptococcus pneumoniae, were the most frequently coded 
pathogens in 1993. There were decreases in the documentation of streptococcal species, 
Haemophilus influenzae, and Pseudomonas, whereas documentation of Staphylococcus 
aureus increased modestly.
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